Comparison of unplanned treatment interruption during CRRT in ICU patients under CVVH (pre + post dilution) or CVVHDF (post-dilution) mode: A retrospective cohort study
- PMID: 40123215
- DOI: 10.1111/nicc.70025
Comparison of unplanned treatment interruption during CRRT in ICU patients under CVVH (pre + post dilution) or CVVHDF (post-dilution) mode: A retrospective cohort study
Abstract
Background: Continuous renal replacement therapy (CRRT) often becomes prematurely interrupted before the planned dose is reached for various reasons. This not only hampers therapeutic efficacy but also escalates blood loss for patients, thereby increasing the nursing workload and patient costs.
Aim: To assess the incidence and filter lifespan of unplanned interruptions in ICU patients undergoing CRRT, continuous veno-venous hemofiltration (CVVH) (pre + post dilution) mode was compared with continuous veno-venous haemodiafiltration (CVVHDF) (post dilution) mode.
Study design: We conducted a retrospective study involving 256 patients: 75 in the CVVH group and 181 in the CVVHDF group. Outcomes such as filter lifespan, unplanned treatment interruptions and catheter complications were compared across the three anticoagulation methods.
Results: A greater proportion of unplanned interruptions was observed in the CVVHDF group. Specifically, filter coagulation led to more frequent interruptions in CVVHDF (p < .05). With citrate anticoagulation, the filters in the CVVH group lasted significantly longer (p = .025). However, under low-molecular-weight heparin or no anticoagulation, filter survival rates were statistically similar between the groups (p > .05). Anticoagulation method (95% CI 1.163-44.95, p = .034), venous pressure (95% CI 0.001-0.004, p = .027) and total serum calcium (95% CI -0.936 to -0.042, p = .033) affect the incidence rate of unplanned treatment interruptions in CVVH (pre- and post-dilution) (p < .05). Venous pressure (95% CI 0.001-0.002, p < .001) and BMI (95% CI -0.936 to -0.042, p = .033) affect the incidence rate of unplanned treatment interruptions in CVVHDF (post-dilution) (p < .05). The adjusted results indicate that PT (HR = 1.09, 95% CI 1.011-1.176, p = .025), venous pressure (HR = 1.013, 95% CI 1.004-1.022, p = .003) and blood flow rate (HR = 1.028, 95% CI 1.002-1.054, p = .034) are potential risk factors for filter lifespan in CVVH (pre- and post-dilution). Venous pressure (HR = 1.005, 95% CI 1.003-1.007, p < .001) is a potential risk factor for filter lifespan in CVVHDF (post-dilution).
Conclusion: Using the CVVH mode with citrate anticoagulation significantly prolongs CRRT filter life and reduces unplanned treatment interruptions. Further prospective, randomised controlled studies are needed to confirm these findings.
Relevance to clinical practice: Exploring the reasons for unplanned treatment interruptions in ICU patients undergoing CRRT under common modes is crucial, serving as an important measure to ensure the quality of treatment. Nurses are the main implementers throughout the entire CRRT process. Understanding the risk factors for unplanned treatment interruptions and filter lifespan can help reduce the economic burden on patients, decrease the workload of medical staff and contribute to the development of plans aimed at improving the quality of care for critically ill patients receiving CRRT.
Keywords: CVVH; CVVHDF; ICU; retrospective study; unplanned treatment interruption.
© 2025 British Association of Critical Care Nurses.
Similar articles
-
Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.Crit Care. 2012 Jun 27;16(3):R111. doi: 10.1186/cc11403. Crit Care. 2012. PMID: 22738289 Free PMC article.
-
A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF.Int J Artif Organs. 2008 Mar;31(3):221-7. doi: 10.1177/039139880803100305. Int J Artif Organs. 2008. PMID: 18373315 Clinical Trial.
-
Comparison of different modalities of continuous renal replacement therapy with regional sodium citrate anticoagulation in paediatric patients.Int J Artif Organs. 2022 Dec;45(12):997-1005. doi: 10.1177/03913988221115447. Epub 2022 Jul 28. Int J Artif Organs. 2022. PMID: 35903018
-
What influences interruption of continuous renal replacement therapy in intensive care unit patients: A review with meta-analysis on outcome variables.Nurs Crit Care. 2025 May;30(3):e13179. doi: 10.1111/nicc.13179. Epub 2024 Oct 12. Nurs Crit Care. 2025. PMID: 39394919 Free PMC article. Review.
-
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.Clin Pharmacokinet. 2007;46(12):997-1038. doi: 10.2165/00003088-200746120-00003. Clin Pharmacokinet. 2007. PMID: 18027987 Review.
References
REFERENCES
-
- Li H, Wang X, Sun H, et al. The impact of timing of continuous renal replacement therapy on the treatment efficacy of infectious acute kidney injury. Chin J Hosp Infect. 2019;29(15):2294‐2298. doi:10.11816/cn.ni.2019‐182068
-
- Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020;10(1):32. doi:10.1186/s13613‐020‐0648‐y
-
- Brandenburger T, Dimski T, Slowinski T, et al. Renal replacement therapy and anticoagulation. Best Pract Res Clin Anaesthesiol. 2017;31(3):387‐401. doi:10.1016/j.bpa.2017.08.005
-
- Park JS, Kim GH, Kang CM, et al. Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous veno‐venous hemodiafiltration. Korean J Intern Med. 2011;26(1):68‐75. doi:10.3904/kjim.2011.26.1.68
-
- He Y, Zhang X, Zhou H, et al. Comparison of solute clearance and anticoagulant effects in different continuous renal replacement therapy modes. J Clin Nephrol. 2018;18(4):211‐214. doi:10.3969/j.issn.1671‐2390.2018.04.004
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources